(Q50857320)

English

Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.

scientific article published on 4 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

0 references

thromboembolism

1 reference

based on heuristic

inferred from title

author name string

J E Delgado Almandoz

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

B M Crandall

2

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

J M Scholz

3

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

J L Fease

4

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

R E Anderson

5

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

Y Kadkhodayan

6

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

D E Tubman

7

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

publication date

4 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

American Journal of Neuroradiology

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

35

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

128-135

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Pipeline flow-diverter stent for endovascular treatment of intracranial aneurysms: preliminary experience in 20 patients with 27 aneurysms

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Immediate procedural outcomes in 35 consecutive pipeline embolization cases: a single-center, single-user experience.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Single center experience with pipeline stent: feasibility, technique, and complications.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Safety of the pipeline embolization device in treatment of posterior circulation aneurysms

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Early postmarket results after treatment of intracranial aneurysms with the pipeline embolization device: a U.S. multicenter experience

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Intracranial aneurysms: midterm outcome of pipeline embolization device--a prospective study in 143 patients with 178 aneurysms

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Clopidogrel hyper-response and bleeding risk in neurointerventional procedures

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3621

21 January 2018

Identifiers

10.3174/AJNR.A3621

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23828107

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50857320&oldid=2043646022"